**8. Conservative approach**

Anticoagulation treatment should be added to aspirin and a P2Y12 receptor inhibitor at the earliest recognition of NSTEMI and continued for at least 48 h to hospital discharge and/ or until symptoms abide and objective markers demonstrate a trend toward normal [121]. Agents include subcutaneous LMWH, intravenous UFH, or fondaparinux, according to clinician choice.
